Fri, Oct 31, 2014, 3:17 AM EDT - U.S. Markets open in 6 hrs 13 mins


% | $
Quotes you view appear here for quick access.

Marina Biotech, Inc. Message Board

  • btimnextmicrosoft btimnextmicrosoft Nov 8, 2012 8:35 PM Flag

    Freed up IP might mean...

    MRNA can now legally announce merger....possibly. Especially since the deopharma deal was 'exclusive'.


    Termination of a Material Definitive Agreement

    Item 1.02 Termination of a Material Definitive Agreement.
    On November 2, 2012, Debiopharm S.A. provided notice to Marina Biotech, Inc. ("Marina") that the Research and License Agreement, dated February 3, 2011, between Marina and Debiopharm, would be terminated effective December 5, 2012, due to Debiopharm's own operational reasons. Marina had previously granted to Debiopharm an exclusive license to develop and commercialize Marina's pre-clinical program in bladder cancer, for all uses in humans and animals for the prevention and treatment of superficial (non-muscle invasive) bladder cancer, in consideration of certain milestone and royalty payments. Following the termination of the license agreement, Marina's bladder cancer program will be returned to us without any obligations beyond those minor activities associated with the termination period and will be reincorporated into

0.93-0.02(-2.11%)Oct 30 3:58 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.